![Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain - Voutsas - 2007 - International Journal of Cancer - Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain - Voutsas - 2007 - International Journal of Cancer -](https://onlinelibrary.wiley.com/cms/asset/ee335ff5-2356-42c4-9551-c75d3c756a87/mfig004.jpg)
Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain - Voutsas - 2007 - International Journal of Cancer -
![Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40425-016-0183-4/MediaObjects/40425_2016_183_Fig1_HTML.gif)
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text
![Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain - Voutsas - 2007 - International Journal of Cancer - Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain - Voutsas - 2007 - International Journal of Cancer -](https://onlinelibrary.wiley.com/cms/asset/5d5e3f83-3b61-4383-84e6-c8846660e028/mfig005.jpg)
Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain - Voutsas - 2007 - International Journal of Cancer -
![Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365918301688-gr1.jpg)
Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect
![Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40425-016-0183-4/MediaObjects/40425_2016_183_Fig3_HTML.gif)
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text
![Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review | Acta Pharmacologica Sinica Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review | Acta Pharmacologica Sinica](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Faps.2017.212/MediaObjects/41401_2018_95_Fig3_HTML.jpg)
Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review | Acta Pharmacologica Sinica
![Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40425-016-0183-4/MediaObjects/40425_2016_183_Fig5_HTML.gif)
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text
![Development and Characterization of a Self-Nanoemulsifying Drug Delivery System Comprised of Rice Bran Oil for Poorly Soluble Drugs | SpringerLink Development and Characterization of a Self-Nanoemulsifying Drug Delivery System Comprised of Rice Bran Oil for Poorly Soluble Drugs | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1208%2Fs12249-018-1274-y/MediaObjects/12249_2018_1274_Fig3_HTML.png)
Development and Characterization of a Self-Nanoemulsifying Drug Delivery System Comprised of Rice Bran Oil for Poorly Soluble Drugs | SpringerLink
![Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365918301688-gr3.jpg)
Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect
![Use of natural antimicrobials to improve the quality characteristics of fresh “Phyllo” – A dough-based wheat product – Shelf life assessment - ScienceDirect Use of natural antimicrobials to improve the quality characteristics of fresh “Phyllo” – A dough-based wheat product – Shelf life assessment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0740002016302878-gr1.jpg)
Use of natural antimicrobials to improve the quality characteristics of fresh “Phyllo” – A dough-based wheat product – Shelf life assessment - ScienceDirect
![Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365918301688-gr7.jpg)
Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect
![Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review. - Abstract - Europe PMC Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6289472/bin/41401_2018_95_Fig2_HTML.jpg)
Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review. - Abstract - Europe PMC
![Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365918301688-gr2.jpg)
Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation - ScienceDirect
![Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40425-016-0183-4/MediaObjects/40425_2016_183_Fig4_HTML.gif)
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text
![Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40425-016-0183-4/MediaObjects/40425_2016_183_Fig2_HTML.gif)
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer | Full Text
![Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain - Voutsas - 2007 - International Journal of Cancer - Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain - Voutsas - 2007 - International Journal of Cancer -](https://onlinelibrary.wiley.com/cms/asset/4f3cf165-6b57-4402-a43f-f80c4e143b60/mfig006.jpg)